Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

NCT07312786 | Recruiting

• 1 other identifier: 707168
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 2

Brief Summary

The goal of this study is to determine the feasibility of implementing a mobile health application for breast and colorectal cancer survivors following primary treatment. Developed in collaboration with Seamless MD, the intervention acts as an information hub, providing users with timely and evidence-based information related to follow-up care as well as health system/community-based resources and programs to meet their needs during this period of care. The goal of the intervention is to encourage open communication regarding survivorship expectations and provide survivors with appropriate information and support to meet their needs. This study will:

1. 1.Test the feasibility of implementing the virtual intervention at two cancer centres in Atlantic Canada (Nova Scotia and New Brunswick)
2. 2.Gather feedback regarding the intervention from cancer survivors and healthcare providers.

Conditions

Breast Cancer Survivor; Colorectal Cancer Survivors

Keywords

Cancer Survivorship; SeamlessMD; Supported self-management; Survivorship app

Outcome Measures

Primary Outcomes (4)

• Recruitment

  Case report forms will be used to track recruitment metrics. The following demographics will be collected to monitor the diversity of those participating: cancer type (breast, colorectal), stage at diagnosis (in situ, stage 1, stage 2, stage 3, do not know), age (in years, prefer not to say), sex assigned at birth (male, female, intersex, prefer not to say), gender (man, woman, non-binary, other, prefer not to say), residence (rural, suburban, urban, prefer not to say), and highest level of education achieved (less than high school, high school, some post-secondary (college or university), diploma or degree, prefer not to say).

  During enrollment

• Retention

  Case report forms will be used to track retention metrics.

  Enrollment to day 180

• Usage of the Intervention

  Usage metrics will be collected using the SeamlessMD software to determine the following: 1) how often the intervention was accessed by participants, 2) what elements of the intervention were accessed most, and 3) what elements of the program were utilized the least.

  Baseline to day 180

• Survivor and Provider Acceptability and Experience

  Assessed via one-on-one semi-structured interviews with a sub-sample of study participants and providers at both study sites. Semi-structured interviews were chosen over focus groups for this component because the research team is seeking individual experiences with the intervention. Interviews will be carried out by a member of the research team on video conferencing software using a predetermined interview guide and will take approximately 45 minutes. The questions will center around the study participant's follow-up care experience while being supported by the intervention. Interviews with providers will focus on the feasibility and acceptability of the supportive self-management tool.

  Interviews with survivor participants will be conducted after having access to the intervention for 180 days.

Secondary Outcomes (3)

• Fear of Recurrence

  Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.

• Patient Activation

  Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.

• Information Provision

  Outcomes will be captured at baseline (study entry), on days 90 and 180, directly through the Seamless MD app software.

Study Arms (1)

virtual self-management intervention

EXPERIMENTAL

Behavioral: virtual self-management intervention

Interventions

virtual self-management intervention BEHAVIORAL

The intervention is a supportive information and self-management tool housed on the SeamlessMD mobile app, created in collaboration with the SeamlessMD development program and informed by foundational research. The application will be used as an information hub and self-management/navigation tool alongside usual care, to address the physical, psychosocial, and practical needs of breast and colorectal cancer survivors. Note that the intervention will not seek to change or impact a survivor's follow-up care plan, as decided upon by the participant and their care team.

virtual self-management intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults older than 18 years, capable of providing informed consent
• Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago

Sponsors & Collaborators

• Canadian Cancer Society (CCS): collaborator
• Nova Scotia Health Authority: lead

Study Sites (2)

Saint John Regional Hospital

Saint John, New Brunswick, Canada

NOT YET RECRUITING

Centre for Clinical Research QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 1V7, Canada

RECRUITING

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: NSHealth Affiliate Scientist

Study Record Dates

• First Submitted: November 24, 2025
• First Posted: December 31, 2025
• Study Start: April 1, 2026
• Primary Completion (Estimated): December 1, 2026
• Study Completion (Estimated): December 1, 2027
• Last Updated: March 17, 2026

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

CA (2)